FrancophonIA/ELRC3.0 huggingface dataset:
English: Converting patients from the vitamin K antagonist warfarin (INR 2.0 to 3.0) to rivaroxaban (20 mg) or from rivaroxaban (20 mg) to warfarin (INR 2.0 to 3.0) increased prothrombin time/INR (Neoplastin)
Croatian: Prelazak bolesnika s antagonista vitamina K, varfarina (INR 2,0 do 3,0) na rivaroksaban (20 mg) ili s rivaroksabana (20 mg) na varfarin (INR 2,0 do 3,0) produljio je protrombinsko vrijeme/INR (Neoplastin) više nego aditivno (mogu se uočiti pojedinačne vrijednosti INR do 12), dok su učinci na aPTV, inhibiciju aktivnosti faktora Xa i endogeni trombinski potencijal bili aditivni.
English: uncommon cases of generalised pruritus), rash, ecchymosis, cutaneous and subcutaneous haemorrhage
Croatian: Poremećaji kože i potkožnog tkiva Svrbež (uključujući manje česte slučajeve generaliziranog svrbeža), osip, ekhimoza, kožno i potkožno krvarenje
English: EU/1/08/472/014 98 film-coated tablets
Croatian: EU/1/08/472/014 98 filmom obloženih tableta
English: Converting from Vitamin K Antagonists (VKA) to Xarelto When converting patients from VKAs to Xarelto, International Normalised Ratio (INR) values could be falsely elevated after the intake of Xarelto.
Croatian: International Normalised Ratio, INR) mogu biti lažno povećane nakon uzimanja lijeka Xarelto.
English: EU/1/08/472/042 14 film-coated tablets
Croatian: EU/1/08/472/042 14 filmom obloženih tableta
English: Xarelto 15 mg film-coated tablets
Croatian: NAZIV LIJEKA Xarelto 15 mg filmom obložene tablete
English: SC Bayer SRL Tel: +40-(0)21-528 59 00
Croatian: Tel: +40-(0)21-528 59 00
English: PP/Aluminium foil blisters in cartons of 10, 14, 28 or 98 film-coated tablets or perforated unit dose blisters in cartons of 10 x 1, or 100 x 1 or in multipacks containing 100 (10 packs of 10 x 1) filmcoated tablets.
Croatian: PP/aluminij blisteri u kutijama s po 10, 14, 28 ili 98 filmom obloženih tableta ili perforirani blisteri s jediničnim dozama u kutijama od po 10 x 1, 100 x 1 ili višestruka pakiranja koja sadrže 100 (10 pakiranja od 10 x 1) filmom obloženih tableta.
English: They come in blisters in cartons of 10, 14, 28 or 98 film-coated tablets or in unit dose blisters in cartons of 10 x 1 or 100 x 1 or in multipacks comprising 10 cartons, each containing 10 x 1 film-coated tablets or in bottles of 100 film-coated tablets.
Croatian: - u blisterima u kutijama od po 10, 14, 28 ili 98 filmom obloženih tableta ili - u blisterima s jediničnim dozama u kutijama od 10 x 1 ili 100 x 1 ili - u višestrukim pakiranjima od 10 kutija od kojih svaka sadrži 10 x 1 filmom obloženu tabletu ili - u bocama sa 100 filmom obloženih tableta.
English: Uncommon (may affect up to 1 in 100 people) - bleeding into the brain or inside the skull - bleeding into a joint causing pain and swelling - thrombocytopenia (low number of platelets, which are cells that help blood to clot)
Croatian: Manje često (mogu se javiti u do 1 na 100 osoba): - krvarenje u mozak ili unutar lubanje - krvarenje u zglob koje uzrokuje bol i oticanje
English: EU/1/08/472/002 10 film-coated tablets
Croatian: EU/1/08/472/002 10 filmom obloženih tableta
English: 5 mg coadministered with ASA or 10 mg alone
Croatian: 5 mg ili 10 mg primijenjenih istodobno uz ASK ili
English: 42 film-coated tablets of 15 mg rivaroxaban and 7 film-coated tablets of 20 mg rivaroxaban (treatment initiation pack)
Croatian: 12. BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/08/472/040 42 filmom obložene tablete od 15 mg rivaroksabana i 7 filmom obloženih tableta od 20 mg rivaroksabana (pakiranje za početak liječenja)
English: hepatocellular injury (inflamed liver incl.
Croatian: P-glycoprotein) i BCRP-a (engl. breast cancer resistance protein).
English: Day 1 - 21: 30 mg Day 22 and onwards: 20 mg After at least 6 months: 10 mg or 20 mg
Croatian: 15 mg dvaput na dan 30 mg Od 22. dana nadalje 20 mg jedanput na dan 20 mg
English: In Einstein PE, 4,832 patients with acute PE were studied for the treatment of PE and the prevention of recurrent DVT and PE.
Croatian: U ispitivanju Einstein PE ispitivano je liječenje plućne embolije i prevencija ponavljajuće duboke venske tromboze i plućne embolije na 4832 bolesnika s akutnom plućnom embolijom.
English: Muscle haemorrhage
Croatian: Tablični prikaz nuspojava
English: Contents of the pack and other information What Xarelto contains
Croatian: Informacija o pomoćnim tvarima Xarelto sadrži laktozu.
English: CAD with heart failure
Croatian: - loše osjećanje - ubrzani otkucaji srca
English: Each film-coated tablet contains 10 mg rivaroxaban.
Croatian: NAVOĐENJE DJELATNE(IH) TVARI Jedna filmom obložena tableta sadrži 10 mg rivaroksabana.
English: Name and address of the manufacturer responsible for batch release
Croatian: PROIZVOĐAČ(I) ODGOVORAN(NI) ZA PUŠTANJE SERIJE LIJEKA U PROMET Nazivi i adrese proizvođača odgovornih za puštanje serije lijeka u promet
English: Take Xarelto on a regular basis and for as long as your doctor keeps prescribing it. Do not stop taking Xarelto without talking to your doctor first.
Croatian: Nemojte prekinuti uzimati Xarelto a da najprije ne porazgovarate s liječnikom.
English: It should be used with caution in ACS and CAD/PAD patients:
Croatian: Mora se primjenjivati s oprezom u bolesnika s akutnim koronarnim sindromom i bolesnika s BKA
English: Fri.
Croatian: Dostupne su
English: Treatment of DVT, treatment of PE and prevention of recurrent DVT and PE The recommended dose for the initial treatment of acute DVT or PE is 15 mg twice daily for the first three weeks followed by 20 mg once daily for the continued treatment and prevention of recurrent DVT and PE.
Croatian: Liječenje duboke venske tromboze (DVT), plućne embolije (PE) i prevencija njihovog ponovnog javljanja od 1. do 21. dana: 30 mg od 22. dana nadalje: 20 mg
English: Respiratory, thoracic and mediastinal disorders
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja Epistaksa, hemoptiza
English: EU/1/08/472/034 100 film-coated tablets (10 x 10 x 1) (multipack) (PP/Aluminium foil blisters)
Croatian: EU/1/08/472/033 100 x 1 filmom obložena tableta (blisteri od PP/aluminijska folija)
English: Information about excipients
Croatian: Prijavljivanje nuspojava
English: Film-coat
Croatian: DRESS sindrom
English: All-cause mortality
Croatian: Smrtnost od svih uzroka 208
English: Xarelto 10 mg
Croatian: Xarelto 10 mg jedanput na dan
English: Warfarin titrated to a target INR of 2.5 (therapeutic range 2.0 to 3.0) Event rate (100 ptyr)
Croatian: a od 2,5 (terapijski raspon od 2,0 do 3,0)
English: Symptomatic recurrent VTE 17
Croatian: Simptomatski ponavljajući VTE
English: EU/1/08/472/022 100 film-coated tablets (10 x 10 x 1) (multipack) (PP/Aluminium foil blisters)
Croatian: EU/1/08/472/032 10 x 1 filmom obložena tableta (blisteri od PP/aluminijska folija)
English: Postprocedural haemorrhage (incl.
Croatian: Do datuma monitoring, SCEM).
English: Xarelto 2.5 mg bid in combination with ASA 100 mg od, N=9152 n (Cum.
Croatian: Usporedba XARELTO 2,5 mg bid, ASK 100 mg od vs ASK 100 mg od
English: In the clinical studies mucosal bleedings (i.e. epistaxis, gingival, gastrointestinal, genito urinary including abnormal vaginal or increased menstrual bleeding) and anaemia were seen more frequently during long term rivaroxaban treatment compared with VKA treatment.
Croatian: U kliničkim ispitivanjima krvarenje iz sluznica (tj. epistaksa, krvarenje desni, gastrointestinalno krvarenje, te genitourinarno krvarenje uključujući abnormalno vaginalno ili pojačano menstruacijsko krvarenje) i anemija zabilježeni su češće tijekom dugotrajnog liječenja rivaroksabanom u usporedbi s liječenjem antagonistima vitamina K. Stoga, osim adekvatnog kliničkog praćenja, laboratorijsko određivanje hemoglobina/hematokrita može biti vrijedno za otkrivanje okultnog krvarenja i određivanje kliničkog značaja vidljivog krvarenja, prema procjeni.
English: FeverA, peripheral oedema, decreased general strength and energy (incl.
Croatian: smanjenje opće snage i energije (uključujući umor i asteniju)
English: Xarelto 15 mg Xarelto 20 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Xarelto 20 mg
English: Protamine sulphate and vitamin K are not expected to affect the anticoagulant activity of rivaroxaban.
Croatian: K utjecali na antikoagulacijsku aktivnost rivaroksabana.
English: DOSE
Croatian: Ukupni
English: Dosing recommendations before and after invasive procedures and surgical intervention If an invasive procedure or surgical intervention is required, Xarelto 20 mg should be stopped at least 24 hours before the intervention, if possible and based on the clinical judgement of the physician.
Croatian: Ako je potreban invazivni postupak ili kirurški zahvat Xarelto 20 mg se mora prestati uzimati najmanje 24 sata prije zahvata, ako je to moguće i na temelju kliničke procjene liječnika.
English: All doses should be taken every 12 hours.
Croatian: Sve doze treba uzimati svakih 12 sati.
English: If this is not possible, it may be taken with a light meal.
Croatian: Ako to nije moguće, može se uzeti uz lagani obrok.
English: Zerit should be taken on an empty stomach, at least one hour before a meal.
Croatian: Zerit se treba uzimati na prazan želudac, najmanje jedan sat prije obroka.
English: Zerit stavudine
Croatian: Zerit stavudin
English: This summary was last updated in 04-2016.
Croatian: Ovaj je sažetak posljednji put ažuriran u 04.2016.
English: The capsules should be swallowed whole or opened carefully and their contents mixed with food.
Croatian: Kapsule treba cijele progutati ili ih pažljivo otvoriti te njihov sadržaj pomiješati s hranom.
English: It is available as capsules containing 15, 20, 30 and 40 mg stavudine.
Croatian: Dostupan je u obliku kapsula s 15, 20, 30 i 40 mg stavudina.
English: The full EPAR for Zerit can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Croatian: Cjeloviti EPAR za lijek Zerit nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: Other information about Zerit
Croatian: Ostale informacije o lijeku Zerit
English: What is Zerit?
Croatian: Što je Zerit?
English: The European Commission granted a marketing authorisation valid throughout the European Union for Zerit on 8 May 1996.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje je za lijek Zerit na snazi u Europskoj uniji od 8. svibnja 1996.
English: The effectiveness of Zerit was assessed in four main studies.
Croatian: Učinkovitost lijeka Zerit ispitivana je četirima glavnim ispitivanjima.
English: This study measured survival rates.
Croatian: To je ispitivanje mjerilo stope preživljavanja.
English: Why has Zerit been approved?
Croatian: Zašto je Zerit odobren?
English: Patients taking either of two doses of Zerit also had similar survival rates over 22 weeks.
Croatian: Bolesnici koji su uzimali jednu od dviju doza lijeka Zerit također su imali slične stope preživljavanja tijekom 22 tjedna.
English: The dose to use is calculated based on the age and weight of the patient.
Croatian: Doza se izračunava na temelju dobi i tjelesne težine bolesnika.
English: The most common side effects when taking Zerit (seen in between 1 and 10 patients in 100) are peripheral neuropathy (damage to the nerves in the extremities causing tingling, numbness and pain in the hands and feet), diarrhoea, nausea, abdominal (stomach) pain, dyspepsia (heartburn), tiredness, lipoatrophy (a loss of fat in some areas of the body which can cause disfigurement), dizziness, insomnia (difficulty sleeping), abnormal thinking or dreams, somnolence (sleepiness), headache, depression, rash, pruritus (itching) and hyperlactataemia (elevated lactic acid levels in the blood).
Croatian: Najčešće su nuspojave pri uzimanju lijeka Zerit (zabilježene u između 1 i 10 na 100 bolesnika) periferna neuropatija (oštećenje živaca koje uzrokuje trnce, bol i utrnulost u šakama i stopalima), proljev, mučnina, bol u trbuhu (trbobolja), disepsija (žgaravica), umor, lipoatrofija (gubitak masnoća u određenim dijelovima tijela koji može uzrokovati izobličenje), omaglica, nesanica (teškoće sa spavanjem), abnormalno razmišljanje ili snovi, somnolencija (pospanost), glavobolja, depresija, osip, pruritus (svrbež) i hiperlaktatemija (povišene razine mliječne kiseline u tijelu).
English: Zerit is to be used for as short a time as possible and the patients switched to appropriate alternatives whenever possible.
Croatian: Zerit se treba primjenjivati tijekom što kraćeg razdoblja, a bolesnicima propisati odgovarajuće alternative kad god je to moguće.
English: Zerit must not be used in people who are taking another HIV medicine called didanosine, which can also have toxic effects on mitochondria.
Croatian: Zerit se ne smije primjenjivati u ljudi koji uzimaju drugi lijek za HIV koji se naziva didanozin, koji također može imati toksične učinke na mitohondrije.
English: What is the risk associated with Zerit?
Croatian: Koji su rizici povezani s lijekom Zerit?
English: CD4 T cells are white blood cells that are important in helping to fight infections, but which are killed by HIV.
Croatian: CD4 T stanice su bijele krvne stanice koje su važne u borbi protiv infekcija, ali HIV ih ubija.
English: This is a summary of the European public assessment report (EPAR) for Zerit.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Zerit.
English: Babies less than 13 days old should be given 0.5 mg/kg body weight.
Croatian: Novorođenčad mlađa od 13 dana treba primati 0,5 mg/kg tjelesne težine.
English: Treatment with Zerit should be initiated by a doctor who has experience in the treatment of HIV infection.
Croatian: Liječenje lijekom Zerit mora započeti liječnik s iskustvom u liječenju infekcije HIV-om.
English: By blocking this enzyme, Zerit, taken in combination with other antiviral medicines, reduces the amount of HIV in the blood and keeps it at a low level.
Croatian: Blokiranjem ovog enzima, Zerit, koji se uzima zajedno s drugim protuvirusnim lijekovima, snižava količinu HIV-a u krvi te je održava na niskoj razini.
English: Its main measure of effectiveness was how long it took for the patients to develop a disease associated with AIDS or to die.
Croatian: Glavno mjerilo učinkovitosti bilo je razdoblje potrebno da bolesnici obole od bolesti povezane s AIDS-om ili da umru.
English: Patients taking Zerit should be assessed frequently.
Croatian: Zerit potrebno je često pregledavati.
English: The patients' CD4 cell counts also rose from around 280 cells/mm3 before treatment by an average of around 185 cells/mm3.
Croatian: Broj CD4 stanica u bolesnika također je porastao s otprilike 280 stanica/mm3 prije liječenja za prosječno otprilike 185 stanica/mm3.
English: For more information about treatment with Zerit, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Zerit pročitajte u uputi o lijeku (također dio EPAR-a) ili se obratite svom liječniku ili ljekarniku.
English: The main measures of effectiveness were the levels of HIV in the blood (viral load) and the number of CD4 T cells in the blood (CD4 cell count) after 48 weeks of treatment.
Croatian: Glavno mjerilo učinkovitosti bile su koncentracije HIV-a u krvi (virusno opterećenje) i broj CD4 T stanica u krvi (broj CD4 stanica) nakon 48 tjedana liječenja.
English: The studies showed that Zerit could reduce the rates of disease progression in HIV-infected patients.
Croatian: Ispitivanja su pokazala da Zerit može smanjiti brzinu napredovanja bolesti u bolesnika zaraženih HIV-om.
English: Zerit is used for as short a time as possible and only when other antiviral medicines cannot be used.
Croatian: Zerit se primjenjuje tijekom što kraćeg razdoblja i samo ako se ne mogu primijeniti drugi protuvirusni lijekovi.
English: Three side effects are possibly related to the medicine's toxic effect on mitochondria (the energyproducing components within cells): lipoatrophy, lactic acidosis (a build-up of lactic acid in the body) and peripheral neuropathy.
Croatian: Postoji mogućnost da su tri nuspojave povezane s toksičnim učinkom lijeka na mitohondrije (sastavni dijelovi stanica koji proizvode energiju): lipoatrofija, laktacidoza (nakupljanje mliječne kiseline u tijelu) i periferna neuropatija.
English: It blocks the activity of reverse transcriptase, an enzyme produced by HIV that allows it to infect cells in the body and make more viruses.
Croatian: On inhibira djelovanje reverzne transkriptaze, enzima koji stvara HIV, a koji virusu omogućuje da zarazi stanice u tijelu i stvori veći broj virusa.
English: These side effects are serious, usually appear with long-term use and are more commonly seen with Zerit than with other NRTI medicines.
Croatian: Te su nuspojave ozbiljne, obično se javljaju pri dugoročnoj upotrebi te su češće zabilježene pri upotrebi lijeka Zerit nego pri upotrebi drugih NRTI lijekova.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Zerit.
Croatian: Objašnjava kako je Odbor za lijekove za humanu uporabu (CHMP) ocijenio lijek da bi donio svoje mišljenje u korist izdavanja odobrenja za stavljanje lijeka u promet te preporuke o uvjetima za primjenu lijeka Zerit.
English: What is Zerit used for?
Croatian: Za što se Zerit koristi?
English: Adults weighing less than 60 kg and children weighing over 30 kg take a dose of 30 mg, and adults over 60 kg take 40 mg. Children over the age of 14 days receive 1 mg per kilogram body weight, unless they weigh more than 30 kg.
Croatian: Odrasle osobe koje teže manje od 60 kg i djeca koja teže više od 30 kg primaju dozu od 30 mg, a odrasle osobe s više od 60 kg primaju 40 mg.
English: Patients taking Zerit alone developed an AIDS-related disease or died at a similar rate to those taking zidovudine.
Croatian: Bolesnici koji uzimaju samo Zerit oboljeli su od bolesti povezane s AIDS-om ili su umrli tijekom sličnog razdoblja kao i oni koji su uzimali zidovudin.
English: Zerit is also available as a powder to make up into an oral solution.
Croatian: Zerit je dostupan i kao prašak za pripremu oralne otopine.
English: Since its authorisation, post-marketing reports and published literature regarding the side effects of Zerit have led the CHMP to update the prescribing information for Zerit, recommending that it should be used for as short a time as possible and only when other antiviral medicines cannot be used.
Croatian: Od odobrenja lijeka, izvješća nakon stavljanja lijeka u promet i objavljena literatura o nuspojavama lijeka Zerit potakla je CHMP da ažurira informacije o propisivanju lijeka Zerit, preporučujući da se primjenjuje tijekom što kraćeg razdoblja i samo ako se ne mogu primijeniti drugi protuvirusni lijekovi.
English: Zerit does not cure HIV infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS.
Croatian: Lijekom Zerit ne liječi se infekcija HIV-om ni AIDS, no njegovom primjenom može se odgoditi narušavanje imunološkog sustava te razvoj infekcija i bolesti povezanih s AIDS-om.
English: Zerit is used in combination with other antiviral medicines to treat adults and children who are infected with human immunodeficiency virus (HIV), the virus that causes acquired immune deficiency syndrome (AIDS).
Croatian: Zerit se koristi u kombinaciji s drugim protuvirusnim lijekovima za liječenje odraslih osoba i djece koja su zaražena virusom humane imunodeficijencije (HIV) koji uzrokuje sindrom stečene imunodeficijencije (AIDS).
English: The second study compared two doses of Zerit in over 13,000 patients who did not respond to, or could not take, other types of antiviral medicine.
Croatian: U drugom ispitivanju uspoređivane su dvije doze lijeka Zerit na više od 13.000 bolesnika na koje druge vrste protuvirusnih lijekova nisu imale učinka ili ih nisu mogli uzimati.
English: Zerit is an antiviral medicine containing the active substance stavudine.
Croatian: Zerit je protuvirusni lijek koji sadrži djelatnu tvar stavudin.
English: Two further studies assessed the effectiveness of Zerit, taken in combination with lamivudine and efavirenz (other antiviral medicines) in 467 treatment-naïve patients (who had not taken treatment for HIV infection before).
Croatian: U dvjema dodatnim ispitivanjima ocijenjena je učinkovitost lijeka Zerit kad se uzimao u kombinaciji s lamivudinom i efavirenzom (drugim protuvirusnim lijekovima) na 467 bolesnika koji prethodno nisu liječeni (koji prije toga nisu primali liječenje za infekciju HIV-om).
English: The active substance in Zerit, stavudine, is a nucleoside reverse transcriptase inhibitor (NRTI).
Croatian: Djelatna tvar lijeka Zerit, stavudin, jest nukleozidni inhibitor reverzne transkriptaze (NRTI).
English: The first study compared the effects of Zerit taken alone with those of zidovudine (another antiviral medicine) in 822 HIV-infected patients who had been taking zidovudine for at least six months.
Croatian: U prvom ispitivanju uspoređivani su učinci lijeka Zerit, kad se primjenjivao samostalno, s učincima zidovudina (drugog protuvirusnog lijeka) na 822 bolesnika zaraženih HIV-om koji su zidovudin uzimali tijekom najmanje šest mjeseci.
English: The CHMP decided that Zerit's benefits are greater than its risks and recommended that it be given marketing authorisation.
Croatian: CHMP je odlučio da koristi lijeka Zerit nadmašuju s njim povezane rizike te je preporučio izdavanje odobrenja za stavljanje lijeka u promet.
English: The oral solution should be used in patients below three months of age.
Croatian: U bolesnika mlađih od tri mjeseca treba se primjenjivati oralna otopina.
English: When taken in combination with lamivudine and efavirenz, around 70% of the patients taking Zerit had viral loads below 400 copies/ml after 48 weeks.
Croatian: Otprilike 70 % bolesnika koji su uzimali Zerit imali su virusna opterećenja manja od 400 kopija/ml nakon 48 tjedana kada su ga uzimali u kombinaciji s lamivudinom i efavirenzom.
English: What benefit has Zerit shown during the studies?
Croatian: Koje su koristi lijeka Zerit utvrđene u ispitivanjima?
English: The dose may need to be adjusted in patients who have problems with their kidneys or experience certain side effects.
Croatian: Bolesnicima koji imaju problema s bubrezima ili kod kojih se pojave određene nuspojave možda će trebati prilagoditi dozu.
English: For the full list of side effects and restrictions with Zerit, see the package leaflet.
Croatian: Potpuni popis nuspojava i ograničenja zabilježenih pri primjeni lijeka Zerit potražite u uputi o lijeku.
English: How is Zerit used?
Croatian: Kako se Zerit koristi?
English: How does Zerit work?
Croatian: Kako djeluje Zerit?
English: How has Zerit been studied?
Croatian: Kako je lijek Zerit ispitivan?
English: 12 January 2015
Croatian: 12. siječnja 2015.
English: Why was Seasonique reviewed?
Croatian: Zašto je Seasonique pregledan?
English: What are the conclusions of the CHMP?
Croatian: Koji su zaključci CHMP-a?
English: What is Seasonique?
Croatian: Što je Seasonique?
English: Slovenia).
Croatian: Rumunjska, Slovačka i Slovenija).
English: Seasonique is an oral contraceptive for women.
Croatian: Seasonique je oralni kontraceptiv za žene.
English: The European Commission issued an EU-wide legally binding decision on 12 January 2015.
Croatian: Europska komisija donijela je odluku koja je pravno obvezujuća na području cijelog EU-a 12. siječnja
English: It is available as blister packs containing 91 tablets to be taken once a day in the order shown on the pack.
Croatian: Dostupan je u obliku blister pakiranja koja sadrže 91 tabletu koje se uzimaju jednom na dan redoslijedom prikazanim na ambalaži.